1. Virtual drug screen reveals context‐dependent inhibition of cardiomyocyte hypertrophy
   Taylor G. Eggertsen et al, 2023, British Journal of Pharmacology CrossRef
2. How does NFAT3 regulate the occurrence of cardiac hypertrophy?
   Wang Hui et al, 2023, IJC Heart & Vasculature CrossRef
3. Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes
   Mingming Zhao et al, 2011, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
4. MicroRNA-29a-3p attenuates ET-1-induced hypertrophic responses in H9c2 cardiomyocytes
   Man Li et al, 2016, Gene CrossRef
5. Cardioprotection of Controlled and Cardiac-Specific Over-Expression of A2A-Adenosine Receptor in the Pressure Overload
   Eman A. Hamad et al, 2012, PLoS ONE CrossRef
6. Rosuvastatin prevents pressure overload-induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats
   XUE XU et al, 2013, Molecular Medicine Reports CrossRef